4
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Schedule dependent tumour growth delay, DNA cross-linking and pharmacokinetic parameters in target tissues with cis-diamminedichloroplatinum(II) and etanidazole with or without hyperthermia or radiation

, , &
Pages 773-784 | Received 04 Sep 1990, Accepted 07 Feb 1991, Published online: 09 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

B. A. Bornstein, T. S. Herman, J. L. Hansen, L. Buswell, P. S. Zouranjian, S. M. Fraser, B. A. Teicher, G. K. Svensson & C. N. Coleman. (1995) Pilot study of local hyperthermia, radiation therapy, etanidazole, and cisplatin for advanced superficial tumours. International Journal of Hyperthermia 11:4, pages 489-499.
Read now

Articles from other publishers (9)

Clemens B. Tempfer, Wiebke Solass, Askin Dogan, Lukas A. Hefler & Marc-André Reymond. (2016) Hyperthermic intraperitoneal chemotherapy for women with granulosa cell tumors of the ovary: a systematic review of the literature. Pleura and Peritoneum 1:1, pages 15-22.
Crossref
Ellen L. Jones, Thaddeus V. Samulski, Mark W. Dewhirst, Angeles Alvarez‐Secord, Andrew Berchuck, Daniel Clarke‐Pearson, Laura J. Havrilesky, John Soper & Leonard R. Prosnitz. (2003) A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma. Cancer 98:2, pages 277-282.
Crossref
Beverly A. Teicher. 1997. Anticancer Drug Development Guide. Anticancer Drug Development Guide 145 182 .
Sandra E. Brooks, Timothy T. Korbut, Norman P. Dupuis, Sylvia A. Holden & Beverly A. Teicher. (1995) Cytotoxicity of antitumor platinum complexes withl-buthionine-(R, S)-sulfoximine and/or etanidazole in human carcinoma cell lines sensitive and resistant to cisplatin. Cancer Chemotherapy and Pharmacology 36:5, pages 431-438.
Crossref
Lawrence N. Shulman, Lori Buswell, Howard Goodman, Michael Muto, Ross Berkowitz, Beverly Teicher, Tetsuya Kusumoto, Selwyn J. Hurwitz, Leslie A. Kalish & C. Norman Coleman. (1994) Phase I pharmacokinetic study of the hypoxic cell sensitizer etanidazole with carboplatin and cyclophosphamide in the treatment of advanced ovarian cancer. International Journal of Radiation Oncology*Biology*Physics 29:3, pages 545-548.
Crossref
Beverly A. Teicher. (1994) Hypoxia and drug resistance. Cancer and Metastasis Reviews 13:2, pages 139-168.
Crossref
Shinji Ohno, Zahid H. Siddik, Yuichiro Kido, Leonard A. Zwelling & Joan M. C. Bull. (1994) Thermal enhancement of drug uptake and DNA adducts as a possible mechanism for the effect of sequencing hyperthermia on cisplatin-induced cytotoxicity in L1210 cells. Cancer Chemotherapy and Pharmacology 34:4, pages 302-306.
Crossref
Beverly A. Teicher, Sylvia A. Holden, Vrinda Khandakar & Terence S. Herman. (1993) Addition of a topoisomerase I inhibitor to trimodality therapy [cis-diamminedichloroplatinum(II)/heat/radiation] in a murine tumor. Journal of Cancer Research and Clinical Oncology 119:11, pages 645-651.
Crossref
Beverly A. Teicher, Terence S. Herman, Lawrence Shulman, Glenn Bubley, C. Norman Coleman & Emil FreiIIIIII. (1991) Combination of etanidazole with cyclophosphamide and platinum complexes. Cancer Chemotherapy and Pharmacology 28:3, pages 153-158.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.